ArticleGut2026

Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Yasi Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.